Micrus Endovascular: is a medical device company formed in June 1996 with its corporate headquarters in San Jose, California. Micrus Endovascular manufactures and markets both implantable and disposable medical devices used in the treatment of cerebral vascular diseases.

Micrus currently employs 240 people.  It was incorporated in Delaware in 1996, began commercial sales in 2000 and went public June 15, 2005.  It is listed on the NASDAQ under the trading symbol MEND and is currently traded at $19.00/share. 

To learn more about Micrus, please go directly to their website at: http://www.micrusendovascular.com